190 related articles for article (PubMed ID: 22550086)
1. Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.
Nissenkorn A; Hassin-Baer S; Lerman SF; Levi YB; Tzadok M; Ben-Zeev B
J Child Neurol; 2013 Feb; 28(2):155-60. PubMed ID: 22550086
[TBL] [Abstract][Full Text] [Related]
2. Amantadine in the akinetic-rigid variant of Huntington's disease.
Magnet MK; Bonelli RM; Kapfhammer HP
Ann Pharmacother; 2004; 38(7-8):1194-6. PubMed ID: 15178736
[TBL] [Abstract][Full Text] [Related]
3. Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations.
Levy A; Lang AE
Mov Disord; 2018 Aug; 33(8):1238-1247. PubMed ID: 29436738
[TBL] [Abstract][Full Text] [Related]
4. More than ataxia - Movement disorders in ataxia-telangiectasia.
Teive HAG; Camargo CHF; Munhoz RP
Parkinsonism Relat Disord; 2018 Jan; 46():3-8. PubMed ID: 29249681
[TBL] [Abstract][Full Text] [Related]
5. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
7. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
Cersósimo MG; Scorticati MC; Micheli FE
Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
[TBL] [Abstract][Full Text] [Related]
9. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
Vitale C; Marconi S; Di Maio L; De Michele G; Longo K; Bonavita V; Barone P
Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335
[TBL] [Abstract][Full Text] [Related]
10. Amantadine in Parkinson's disease: pro and contra.
Greulich W; Fenger E
J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
[TBL] [Abstract][Full Text] [Related]
11. Twenty-five years of amantadine therapy in Parkinson's disease.
Danielczyk W
J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
[TBL] [Abstract][Full Text] [Related]
12. Disorders of Upper Limb Movements in Ataxia-Telangiectasia.
Shaikh AG; Zee DS; Mandir AS; Lederman HM; Crawford TO
PLoS One; 2013; 8(6):e67042. PubMed ID: 23826191
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of acute movement disorders in children.
Dale RC; Singh H; Troedson C; Pillai S; Gaikiwari S; Kozlowska K
Dev Med Child Neurol; 2010 Aug; 52(8):739-48. PubMed ID: 20163436
[TBL] [Abstract][Full Text] [Related]
14. Long-term antidyskinetic efficacy of amantadine in Parkinson's disease.
Wolf E; Seppi K; Katzenschlager R; Hochschorner G; Ransmayr G; Schwingenschuh P; Ott E; Kloiber I; Haubenberger D; Auff E; Poewe W
Mov Disord; 2010 Jul; 25(10):1357-63. PubMed ID: 20198649
[TBL] [Abstract][Full Text] [Related]
15. Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.
Gironell A; Kulisevsky J; Pascual-Sedano B; Flamarich D
Mov Disord; 2006 Apr; 21(4):441-5. PubMed ID: 16229019
[TBL] [Abstract][Full Text] [Related]
16. Ataxia-telangiectasia presenting with a novel immunodeficiency.
Perreault S; Bernard G; Lortie A; Le Deist F; Decaluwe H
Pediatr Neurol; 2012 May; 46(5):322-4. PubMed ID: 22520355
[TBL] [Abstract][Full Text] [Related]
17. Ataxia telangiectasia presenting as an extrapyramidal movement disorder and ocular motor apraxia without overt telangiectasia.
Churchyard A; Stell R; Mastaglia FL
Clin Exp Neurol; 1991; 28():90-6. PubMed ID: 1726561
[TBL] [Abstract][Full Text] [Related]
18. Pathological gambling in Parkinson disease is reduced by amantadine.
Thomas A; Bonanni L; Gambi F; Di Iorio A; Onofrj M
Ann Neurol; 2010 Sep; 68(3):400-4. PubMed ID: 20687121
[TBL] [Abstract][Full Text] [Related]
19. Dystonia as presenting manifestation of ataxia telangiectasia : a case report.
Goyal V; Behari M
Neurol India; 2002 Jun; 50(2):187-9. PubMed ID: 12134185
[TBL] [Abstract][Full Text] [Related]
20. [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine].
Malsch U; Bliesath H; Böther K; Ramm H; Lühmann R
Fortschr Neurol Psychiatr; 2001 Feb; 69(2):86-9. PubMed ID: 11253562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
